Showing results (801-810 of 834) with videos related to

Sort By:
Pageof 84
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR TrialMichael Weller, Ghazaleh Tabatabai, Bärbel Kästner, et al.
The Lancet. Digital Health|October 24, 2021
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort studyChandrakanth Jayachandran Preetha, Hagen Meredig, Gianluca Brugnara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in AdultsPatrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trialY Gao, B Weenink, M J van den Bent, et al.
The Journal of Clinical Investigation|August 29, 2024
B cell-based therapy produces antibodies that inhibit glioblastoma growthSi Wang, Brandyn A Castro, Joshua L Katz, et al.
The Lancet. Oncology|February 29, 2024
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort studyAditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, et al.
Elife|March 18, 2020
Wikidata as a knowledge graph for the life sciencesAndra Waagmeester, Gregory Stupp, Sebastian Burgstaller-Muehlbacher, et al.
Nature Communications|December 16, 2025
Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxelMark W Youngblood, Abha Kumari, Yoon-Tae Kang, et al.
Pageof 84